Gennex Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Gennex Laboratories Ltd. on BSE

Load latest

Gennex Laboratories Ltd.

14 Nov 2024

13.02

7.87%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Intimation Of Reconstitution Of Audit Committee, Stakeholders Relationship Committee And …

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in their meeting held on November 14, 2024, reconstituted their Audit Committee, Stakeholders Relationship Committee and Nomination and Remuneration Committee as per details in the attached letter. The intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

14 Nov 2024

13.02

7.87%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors at its meeting held today i.e. November 14, 2024, has approved the appointment of Mr. Akalli Santosh Kumar as the Chief Financial Officer and Key Managerial Person of the Company with effect from November 14, 2024. The details as required under said Regulation and SEBI Circular dated July 13, 2023 is enclosed as Annexure I. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

14 Nov 2024

13.02

7.87%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Statement Of Deviation Or Variation In The Use Of Proceeds …

BSE India

Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, we hereby confirm that there is no deviation or variation in the use of proceeds during the quarter ended September 30, 2024, from the objects stated in the Letter of Offer for the Funds raised by the Company. A Statement of Deviations stating that there is no deviation or variation in the utilization of these proceeds, duly reviewed by the Audit Committee, is attached. We request you to take the above information on record and acknowledge the receipt of the same.

pdf

Gennex Laboratories Ltd.

13 Nov 2024

13.02

7.87%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company Scheduled to be held on Thursday, November 14, 2024 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Half year ended September 30, 2024 along with the Limited Review Report of the Statutory Auditors of the Company. Notice had been published in both Business Standard and Saksham (Local) on November 07, 2024. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

05 Nov 2024

13.02

7.87%

Board Meeting

GENNEX LABORATORIES LTD. - 531739 - Board Meeting Intimation for Consideration And Approval Of Unaudited (Standalone …

BSE India

GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve 1. Consider and adopt the Unaudited Financial Statements (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2024; 2. Consider the Limited Review Reports'' of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter and Half-Year ended September 30, 2024; 3. Reconstitution of the Audit Committee of the Company; 4. Reconstitution of the Nomination & Remuneration Committee of the Company; 5. Reconstitution of the Stakeholders Relationship Committee of the Company; 6. Other Business items.

pdf

Gennex Laboratories Ltd.

28 Oct 2024

13.02

7.87%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Grant Of Test License By Drugs Control Administration, Government Of …

BSE India

We are pleased to inform you that our subsidiary Company, M/s Deccan Remedies Limited has been granted Test License by the Drugs Control Administration, Government of Andhra Pradesh for the purpose of Examination and Test for Chemical and Instrumental Analysis under Form 29. Details of Products covered under Test License for Examination and Test for Chemical and Instrumental Test Analysis are enclosed herewith. Test License granted by the DCA- Government of Andhra Pradesh is enclosed with this letter for your information and for taking the same on record.

pdf

Gennex Laboratories Ltd.

28 Oct 2024

13.02

7.87%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Approval Of Additional Products From Drug Control Administration, Government Of …

BSE India

We are pleased to inform that our Subsidiary Company, M/s Deccan Remedies Limited has received Approval from Drugs Control Administration, Government of Andhra Pradesh granting manufacture of Additional Products under Form 25. List of Additional Products approved for manufacture and sale (Domestic and Export purpose) is enclosed herewith. Approval received from DCA- Government of Andhra Pradesh is enclosed with this letter for your information and for taking the same on record

pdf

Gennex Laboratories Ltd.

25 Oct 2024

13.02

7.87%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

With reference to the captioned subject, pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, we hereby submit the certificate received from M/s R&D Infotech Private Limited, Registrar and Share Transfer Agent of the Company for the Quarter ended September 30, 2024. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

04 Oct 2024

13.02

7.87%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

This has reference to email dated February 20, 2024 regarding BSE observation that required details under SEBI Circular No. 2023/123 dated 13.07.2023 is not mentioned in our Announcement dated February 01, 2024 related to resignation of our Whole Time Director, Mr. T M Gopalakrishnan due to his personal reasons of age and health with effect from January 30, 2024. We are resubmitting the said Corporate Announcement of February 01, 2024 with required information as per Circular No. 2023/123 dated 13.07.2023. This is for your information and record.

pdf

Gennex Laboratories Ltd.

01 Oct 2024

13.02

7.87%

AGM

GENNEX LABORATORIES LTD. - 531739 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time (Listing Regulations), please find enclosed herewith voting results of the 39th AGM of the Company held on September 30, 2024 at 12.30 Hrs through Video Conferencing (VC) / Other Audio Visual Means (OAVM) along with the Consolidated Scrutinizers Report. It is inform to that all resolutions set out in the Notice of the 39th eAGM were duly approved by the shareholders with requisite majority. The voting results along with the Scrutinizers report is also being enclosed to this letter and uploaded on the website of the Company i.e. www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same.

pdf

Is Gennex Laboratories Ltd. worth buying?

126 Votes:

Buy 83.33%

Sell 6.35%

Hold 10.32%